NEW YORK--(BUSINESS WIRE)--Mixlab, the leading modern veterinary pharmacy, has acquired NexGen Animal Health, based in Weatherford, Texas, to expand its state-of-the-art compounding pharmacy services beyond companion animals into large animals, with continued financial backing from Vanterra Ventures.

纽约--（商业新闻短讯）--领先的现代兽医药房Mixlab收购了位于德克萨斯州威瑟福的NexGen Animal Health，将其最先进的复合药房服务从伴侣动物扩展到大型动物，并得到了Vanterra Ventures的持续财政支持。

NexGen specializes in the formulation of innovative products and unique compounds for the care of equine, exotic, wildlife and zoo animals. Mixlab will leverage its proprietary technology platform to create a better pharmacy experience for the benefit of large animal practitioners and owners, as well as to increase production efficiency and fuel further growth..

NexGen专注于创新产品和独特化合物的配方，用于照顾马，外来动物，野生动物和动物园动物。Mixlab将利用其专有技术平台，为大型动物从业者和所有者创造更好的药房体验，并提高生产效率和推动进一步增长。。

In 2023, Mixlab partnered with over 7,000 veterinarians to help 55,000 animal owners across 6,700 cities. With this acquisition, Mixlab will considerably expand its reach outside of the companion animal space with the same exceptional customer service, commitment to quality, and industry-leading delivery times it’s known for.

2023年，Mixlab与7000多名兽医合作，帮助6700个城市的55000名动物主人。通过此次收购，Mixlab将以其卓越的客户服务、对质量的承诺以及业界领先的交付时间，大大扩展其在伴侣动物领域之外的影响力。

The company will operate a fourth pharmacy location in Texas, adding to its current operations in New York, California and Florida, to grow its capacity, formulary and customer care team and position itself to meet rising demand for its products and services..

该公司将在德克萨斯州经营第四家药店，增加其在纽约、加利福尼亚和佛罗里达州的现有业务，以扩大其产能、处方集和客户服务团队，并使自己能够满足不断增长的产品和服务需求。。

“This acquisition marks a key milestone for Mixlab as we expand our offering with sterile and non-sterile preparations for the equine, wildlife and zoo markets,” said Mixlab CEO Fred Dijols. “NexGen has built a state-of-the-art facility and shares our commitment to delivering the highest-quality veterinary medications and best-in-class customer experiences.

Mixlab首席执行官弗雷德·迪约斯（FredDijols）表示：“此次收购标志着Mixlab的一个关键里程碑，因为我们将为马、野生动物和动物园市场提供无菌和非无菌制剂。”。“NexGen建立了最先进的设施，并与我们共同致力于提供最高质量的兽药和一流的客户体验。

We look forward to joining hands and delivering exceptional personalized care to our new veterinarian partners and animal owners.”.

我们期待着携手合作，为我们的新兽医合作伙伴和动物主人提供非凡的个性化护理。”。

Over the coming months, Mixlab will further enhance eMix, its proprietary prescription management platform, as well as release a portal specifically for animal owners. The development of these innovative solutions underscores Mixlab’s mission to redefine the pharmacy experience for veterinarians and animal owners..

在接下来的几个月里，Mixlab将进一步增强其专有处方管理平台eMix，并发布专门针对动物所有者的门户。这些创新解决方案的开发突显了Mixlab的使命，即为兽医和动物主人重新定义药房体验。。

About Mixlab

关于Mixlab

Mixlab is the leading modern veterinary pharmacy that partners with veterinarians to make their jobs easier and deliver the highest level of care to animal owners. Mixlab is digitally transforming the veterinarian-led prescription medication process while delivering a superior customer experience. Founded in 2017, Mixlab operates four pharmacies and delivers across all 50 states.

Mixlab是领先的现代兽医药店，与兽医合作，使他们的工作更容易，并为动物主人提供最高水平的护理。Mixlab正在数字化地改变兽医主导的处方药流程，同时提供卓越的客户体验。Mixlab成立于2017年，经营四家药店，并在所有50个州提供服务。

Mixlab has financial backing from Vanterra Ventures, Global Founders Capital, Lakehouse Ventures, Sonoma Brands, Monogram Capital, Brand Foundry, and others. Read more about Mixlab at www.mixlab.com..

Mixlab拥有Vanterra Ventures、Global Founders Capital、Lakehouse Ventures、Sonoma Brands、Monogram Capital、Brand Foundry等的财务支持。有关Mixlab的更多信息，请访问www.Mixlab.com。。